3904
G. V. M. Sharma et al. / Tetrahedron: Asymmetry 14 (2003) 3899–3905
pension) was added slowly at 0°C. After stirring at
room temperature for 30 min, ethyl 2-bromo methyl
acrylate (0.65 g, 3.35 mmol) was added. After 1 h, it
was worked-up and purified as described for 2 to afford
15 (1.265 g, 64%) as a pale yellow syrup; [h]D=+43.0 (c
3.45, CHCl3); IR (neat): 720, 1088, 1376, 1712, 2928
cm−1; 1H NMR (500 MHz, CDCl3): l 7.42 (m, 6H,
Ar-H), 7.27 (m, 6H, Ar-H), 7.21 (m, 3H, Ar-H), 6.16
(dt, 1H, J=2.9, 1.3, 1.3 Hz, olefinic), 5.58 (dt, 1H,
J=2.9, 1.3, 1.3 Hz, olefinic), 4.52 (s, 1H, H-2), 4.47
(ddd, 1H, J=3.1, 5.5, 7.8 Hz, H-4), 4.31(td, 1H, J=
14.0, 1.3, 1.3 Hz, H-7a), 4.17 (q, 2H, J=7.2 Hz,
5.5, 7.7 Hz, H-4), 4.35 (td, 1H, J=12.9, 1.2, 1.2 Hz,
H-7a), 4.24 (q, 2H, J=7.1 Hz, -OCH2CH3), 4.18 (td,
1H, J=12.9, 1.1, 1.1 Hz, H-7b), 4.05 (d, 1H, J=3.3 Hz,
H-3), 3.84 (m, 2H, H-5a, 5b), 3.57 (abq, 2H, J=10.5
6
Hz, -CH6 2OCH3), 3.43 (s, 3H, -OCH3), 1.50 (s, 3H,
-CH3), 1.41 (s, 3H), 1.23 (t, 3H, J=7.1 Hz, OCH2CH6 3);
FABMS (m/z, %): 346 (M+, 4), 355 (8), 281 (29), 242
(40), 147 (60), 73 (100), 55 (60). Anal. calcd for
C16H26O8: C, 55.48; H, 7.57. Found: C, 55.40; H, 7.52.
4.14. 4-Methoxymethyl-6,6,12,14-tetramethyl-(1R,2S,4S,
8S,9R,12S)-3,5,7,10,13-pentaoxa-14-azatetracyclo-
[10.2.1.02,9.04,8]pentadecane 20
-OCH
4.05 (d, 1H, J=3.1 Hz, H-3), 3.49 (abq, 2H, J=11.0
Hz, -CH2OCH3), 3.45 (dd, 1H, J=5.5, 9.2 Hz H-5a),
6 2CH3), 4.12 (td, 1H, J=14.0, 1.3, 1.3 Hz, H-7b),
6
3.38 (s, 3H, -OCH3), 3.28 (dd, 1H, J=9.2, 7.8 Hz,
H-5b), 1.55 (s, 3H), 1.40 (s, 3H), 1.26 (t, 3H, J=7.2 Hz,
To a stirred solution of oxalyl chloride (0.20 mL, 2.28
mmol) in dry CH2Cl2 (5 mL), dry DMSO (0.32 mL,
4.57 mmol) was added at −78°C. After stirring at the
same temperature for 20 min, a solution of 16 (0.60 g,
2.08 mmol) in dry CH2Cl2 (5 mL) was added dropwise
and the reaction mixture stirred for further 3 h. It was
quenched with Et3N (1.73 mL, 12.48 mmol) and stirred
till reaction mixture comes to room temperature. It was
diluted with CH2Cl2 (25 mL) and organic layer was
washed with water (25 mL), brine (25 mL), dried
(Na2SO4) and evaporated to afford 3a-methoxymethyl-
2,2-dimethyl-6-(2-methylallyloxy)-(3aS,5R,6R,6aS)-per-
hydrofuro[2,3-d][1,3]dioxole-5-carbaldehyde 18 (0.50 g,
84%) as a light brown syrup, which was used as such
for the next reaction.
OCH2CH6 3
); FABMS (m/z, %): 345 (M+−243, 10), 380
(20), 243 (100), 165 (24).
4.12. 3a-Methoxymethyl-2,2-dimethyl-6-(2-methylallyl-
oxy)-(3aS,5S,6R,6aS)-perhydrofuro[2,3-d][1,3]dioxol-5-
ylmethanol 16
To a stirred solution of 14 (1.67 g, 3.1 mmol) in CH2Cl2
(15 mL), trifluoroacetic acid (1.64 mL) was added at
0°C and stirred at room temperature for 1 h. It was
quenched with aq. sodium bicarbonate solution (25
mL) and extracted with CH2Cl2 (3×30 mL). Organic
layer was washed with water (25 mL), brine (25 mL)
and dried (Na2SO4). Evaporation of solvent and purifi-
cation of residue by column chromatography (silica gel,
hexane–EtOAc, 3:2) afforded 16 (0.6 g, 66%) as a pale
yellow syrup; [h]D=+32.4 (c 5.50, CHCl3); IR (neat):
A mixture of 18 (0.50 g, 1.75 mmol), N-methyl hydrox-
ylamine hydrochloride (0.146 g, 1.75 mmol) and Et3N
(0.49 mL, 3.50 mmol) in toluene (5 mL) was heated at
reflux for 5 h and worked-up as described for 8 to
afford 20 (0.44 g, 80%) as a white solid; mp 113–115°C;
[h]D=+21.3 (c 0.5, CHCl3); IR (KBr): 1030, 1107, 1369,
1
880, 1040, 1120, 1200, 1360, 1456, 2920, 3456 cm−1; H
NMR (500 MHz, CDCl3): l 5.0–4.88 (m, 2H, olefinic),
4.54 (s, 1H, H-2), 4.40 (dt, 1H, J=3.3, 4.8, 4.8 Hz,
H-4), 4.04 (td, 1H, J=12.5, 1.1 Hz, H-7a), 3.99 (d, 1H,
J=3.3 Hz, H-3), 3.94 (td, 1H, J=4.8, 12.1 Hz, H-5a),
3.88 (td, 1H, J=12.5, 1.1 Hz, H-7b), 3.86 (dd, 1H,
J=4.8, 12.1 Hz, H-5b), 3.61 (abq, 2H, J=12.4 Hz,
1
2912, 2995 cm−1; H NMR (500 MHz, CDCl3): l 4.34
(s, 1H, H-2), 4.26 (ddd, 1H, J=1.1, 1.8, 3.1 Hz, H-4),
4.09 (d, 1H, J=1.8 Hz, H-3), 3.64 (d, 1H, J=10.8 Hz,
H-7a), 3.57 (dd, 1H, J=3.1, 6.4 Hz, H-5), 3.57 (d, 1H,
J=10.8 Hz, H-7b), 3.45 (s, 2H, CH6 2OCH3), 3.45 (s,
3H, -OCH3), 2.75 (s, 3H, N-CH3), 2.67 (d, 1H, J=12.7
Hz, H-6a), 2.19 (ddd, 1H, J=1.1, 6.4, 12.7 Hz, H-6b),
1.50 (s, 3H, CH3), 1.39 (s, 3H, CH3), 1.38 (s, 3H, CH3);
13C NMR (75 MHz, CDCl3) 112.78, 112.22, 85.83,
84.42, 82.32, 79.81, 77.07, 72.75, 66.80, 59.72, 46.59,
33.58, 27.36, 26.26, 25.35; FABMS (m/z, %): 316 (M++
1, 96), 258 (22), 185 (40), 133 (22), 93 (84), 55 (100).
Anal. calcd for C15H25NO6: C, 57.13; H, 7.99. Found:
C, 58.06; H, 7.93.
-CH6 2OCH3), 3.44 (s, 3H, -OCH3), 1.73 (s, 3H, CH3),
1.51 (s, 3H), 1.41 (s, 3H); FABMS (m/z, %): 289
(M++1, 20), 231 (12), 109 (32), 95 (45), 69 (62), 55 (100).
Anal. calcd for C14H24O6: C, 58.32; H, 8.39. Found: C,
58.25; H, 8.33.
4.13. Ethyl 2-[5-hydroxymethyl-3a-methoxymethyl-2,2-
dimethyl-(3aS,5S,6R,6aS)-perhydrofuro[2,3-d][1,3]dioxol-
6-yloxymethyl]acrylate 17
4.15. Ethyl-4-methoxymethyl-6,6,14-trimethyl-(1R,2S,4S,
8S,9R,12S)-3,5,7,10,13-pentaoxa-14-azatetracyclo-
[10.2.1.02,9.04,8]pentadecane-12-carboxylate 21
To a stirred solution of 15 (1.26 g, 2.13 mmol) in
CH2Cl2 (10 mL), trifluoroacetic acid (1.2 mL) was
added at 0°C, stirred at room temperature for 1 h and
worked-up and purified as described for 16 to afford 17
(0.52 g, 70%) as a pale yellow syrup; [h]D=+14.8 (c
5.30, CHCl31); IR (neat): 1120, 1200, 1376, 1712, 2944,
3472 cm−1; H NMR (500 MHz, CDCl3): l 6.32 (dt,
1H, J=2.8, 1.2 Hz, olefinic), 5.82 (dt, 1H, J=2.8, 1.2
Hz, olefinic), 4.57 (s, 1H, H-2), 4.43 (ddd, 1H, J=3.3,
To a stirred solution of oxalyl chloride (0.12 mL, 1.43
mmol) in dry CH2Cl2 (5 mL), dry DMSO (0.2 mL, 2.86
mmol) was added at −78°C. After 20 min, a solution of
17 (0.45 g, 1.30 mmol) in dry CH2Cl2 (5 mL) was added
dropwise. After 3 h, it was quenched with Et3N (1.08
mL, 7.8 mmol) and worked-up as described for 18 to